A Phase 1/ Phase 2 Study of TTHX1114(NM141)

Clinical trial NCT04520321 · COMPLETED

Trial details

NCT number: NCT04520321
Sponsor: Trefoil Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Corneal Endothelial Dystrophy Fuchs Endothelial Corneal Dystrophy Pseudophakic Bullous Keratopathy Endothelial Dysfunction

Start date: 2020-08-19
Primary completion: 2021-04-23
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.